Typical morphology and focal cytokeratin/EMA positivity should alert to this tumor, and TLE-1, a relatively sensitive marker for synovial sarcoma, should be used to avoid the diagnostic dilemma. This evidence concerns the gene TLE1 and synovial sarcoma.